Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (1112)	4/27/1998 4:36:00 PM
From: Rudy Saucillo	Read Replies (3) of 2742

Rick, I spoke with Hal Smith, CIST's PR person, this morning. He stated that Cistron is now actively involved in cancer vaccine research, and that this work involves "an outside party." This is good news and is a natural follow-on to the reacquisition of the GTI (Sandoz/Novartis) sub-license for this research. Hopefully, news of a collaboration will be forthcoming. Interestingly, today's (4/27) BioCentury has a lead article on cancer vaccine research. A number of companies/approaches are discussed. Clearly some of these approaches - as you've outlined previously - are relevant to CIST. This is a great 'primer.' I recommend that anyone interested go to the BioCentury website biocentury.com and request a copy. Hal also mentioned that CIST's flu vaccine work with Novavax and their wound healing work are proceeding. Also, Galton and BlueStone are working closely and are in active discussions with a number of companies. Rudy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next